GGrantIndex
← Search

REPAGLINIDE AS A VIABLE ALTERNATIVE TO PRE-MEAL INSULIN IN CYSTIC FIBROSIS RE

$87M01FY2008RRNIH

Indiana University Indianapolis, Indianapolis IN

Investigators

Linked publications, trials & patents

View original record on NIH RePORTER →